DUBLIN, Ohio--(BUSINESS WIRE)--Navidea Biopharmaceuticals, Inc. (NYSE MKT: NAVB), announces that Rick Gonzalez, President and Chief Executive Officer, will present a corporate overview on Monday, February 8, 2016 at 1:00 PM ET at the 2016 BIO CEO & Investor Conference.
